Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.0400
Abstract: This cohort study assesses the clinicopathological features, outcomes, and adverse events of older patients with metastatic colorectal adenocarcinomas. read more here.
Keywords: site mismatch; association survival; mismatch repair; survival metastatic ... See more keywords
Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz247.118
Abstract: Abstract Background With this study, we aimed to present the impact of malnutrition on the tolerability and efficacy ofchemotheraphy, and overall survival on metastatic gastric cancer (mGC) patients. Methods In this prospective multicenter study, we… read more here.
Keywords: status; metastatic gastric; mgc patients; gastric cancer ... See more keywords
Survival of metastatic metaplastic breast cancer patients receiving chemotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e13126
Abstract: e13126Background: Metaplastic breast cancer (MBC) is a rare, aggressive variant of breast cancer, usually triple negative disease and chemotherapy refractory. Despite this, the standard of care rem... read more here.
Keywords: chemotherapy; breast; metaplastic breast; breast cancer ... See more keywords
Overall survival (OS) in metastatic melanoma since the introduction of immunotherapy: A National Cancer Database analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e19333
Abstract: e19333Background: Metastatic melanoma historically had a very poor prognosis and survival until the utilization of immunotherapy. Ipilimumab, the first immune checkpoint (ICP) inhibitor was approve... read more here.
Keywords: melanoma; melanoma since; since introduction; metastatic melanoma ... See more keywords